These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 4178872)
21. [Comparison of the pharmacological properties of prothixene, promethazine and chlorprothixene]. Metys J; Metysová J; Votava Z Cesk Farm; 1966 Dec; 15(10):526-30. PubMed ID: 4382828 [No Abstract] [Full Text] [Related]
22. [Effect of dipyridamole and prednisolone on the lysophospholipase of erythrocytes]. Ferber E; Munder PG; Fischer H Biochem Z; 1966 Mar; 344(2):218-20. PubMed ID: 5982380 [No Abstract] [Full Text] [Related]
23. [Modifications of erythrocyte permeability caused by chlorpromazine and some other psychotropic drugs]. Revol L; Miachon S C R Seances Soc Biol Fil; 1969; 163(4):888-93. PubMed ID: 4259089 [No Abstract] [Full Text] [Related]
24. Effect of drugs on the hemolysis of rat erythrocytes. Sheppard H; Tsien WH; Burghardt C Biochem Pharmacol; 1969 Sep; 18(9):2215-23. PubMed ID: 5345896 [No Abstract] [Full Text] [Related]
25. [Enzymatic acylation of lysophosphatidic acid, saturated and unsaturated lysolecithin]. Stoffel W; De Tomás ME; Schiefer HG Hoppe Seylers Z Physiol Chem; 1967 Jul; 348(7):882-90. PubMed ID: 5592096 [No Abstract] [Full Text] [Related]
26. [On the ability to modify intestinal function by premedication and anesthesia]. Bergmann H Anaesthesist; 1965 Sep; 14(9):263-9. PubMed ID: 5865468 [No Abstract] [Full Text] [Related]
27. Effects of lysolecithin on the surface properties of human erythrocytes. Marikovsky Y; Brown CS; Weinstein RS; Wortis HH Exp Cell Res; 1976 Mar; 98(2):313-24. PubMed ID: 1253850 [No Abstract] [Full Text] [Related]
28. Influence of incubated serum, lysolecithin, and of bile on human red cell deformability. Rogausch H Bibl Anat; 1977; (16 Pt 2):507-9. PubMed ID: 603594 [No Abstract] [Full Text] [Related]
29. Effects of immune reactions on the red cell membrane. Rosse WF; Lauf PK Semin Hematol; 1970 Jul; 7(3):323-40. PubMed ID: 4193308 [No Abstract] [Full Text] [Related]
31. Studies on the membrane-perturbational effects of drugs and divalent cations utilizing trinitrobenzenesulfonic acid. Godin DV; Ng TW Mol Pharmacol; 1973 Nov; 9(6):802-19. PubMed ID: 4762637 [No Abstract] [Full Text] [Related]
32. The dynamics of erythrocyte membrane cholesterol. Lange Y Prog Clin Biol Res; 1984; 159():137-51. PubMed ID: 6473459 [No Abstract] [Full Text] [Related]
33. Metabolism of red-cell lipids. II. Conversions of lysophosphoglycerides. Mulder E; van den Berg JW; van Deenen LL Biochim Biophys Acta; 1965 Jul; 106(1):118-27. PubMed ID: 5848257 [No Abstract] [Full Text] [Related]
34. [Inhibiting effect of chimyl alcohol on lysolecithin-induced hemolysis]. Safanda J; Holecek V Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(2):171-5. PubMed ID: 4157990 [No Abstract] [Full Text] [Related]
36. Evidence that lysolecithin is an important causal agent of atherosclerosis. Vidaver GA; Ting A; Lee JW J Theor Biol; 1985 Jul; 115(1):27-41. PubMed ID: 4033162 [TBL] [Abstract][Full Text] [Related]
37. Lysolecithin and cell fusion. Poole AR; Howell JI; Lucy JA Nature; 1970 Aug; 227(5260):810-4. PubMed ID: 5432243 [No Abstract] [Full Text] [Related]
38. Accumulation of lysolecithin in rat brain on incubation in vitro. Webster GR; Thompson RH Nature; 1965 Apr; 206(981):296-7. PubMed ID: 5836321 [No Abstract] [Full Text] [Related]
39. Changes in shape and osmotic resistance of human erythrocytes resulted from changes in the lysolecithin content of the membranes. Sato T; Fujii T Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):152-6. PubMed ID: 4833370 [No Abstract] [Full Text] [Related]
40. [On the automatic registration of hemolysis by serum complement and lysolecithin]. Siedentopf HG; Lauenstein K; Fischer H Z Naturforsch B; 1965 Jun; 20(6):569-74. PubMed ID: 4379251 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]